Enzyme replacement therapy for mucopolysaccharidoses: opinions of patients and families

The Journal of Pediatrics
David J ComanMartin B Delatycki

Abstract

To assess the opinions of individuals with mucopolysaccharidoses (MPS) and their parents regarding the use of enzyme replacement therapy (ERT). A validated questionnaire, including hypothetical clinical scenarios about ERT for MPS, was distributed to members of MPS support groups in the United States and Australia. The questionnaire was completed by 249 MPS support group members. Overall, 92% were in favor of ERT where MPS causes severe physical problems but does not affect intellect, and 69% were in favor of ERT where the physical limitations are mild and intellect is spared. Only 47% were in favor of ERT where severe physical and intellectual problems are well established; however, 77% were in favor of ERT in this situation if treatment begun early prolongs life and improves quality of life. Most respondents were in favor of ERT for MPS, even where it would not alter the intellectual deterioration. The medical community has a responsibility to advocate for their patients in situations where ERT is appropriate and recognize the economic burden and "family function burden" ERT can incur.

References

May 1, 1996·Nature Medicine·E Beutler
Jan 26, 1999·JAMA : the Journal of the American Medical Association·P J MeikleW F Carey
Feb 15, 2001·The New England Journal of Medicine·E D KakkisE F Neufeld
May 9, 2002·Expert Opinion on Investigational Drugs·Emil D Kakkis
May 6, 2004·The Journal of Pediatrics·Paul HarmatzJohn J Hopwood
Jun 11, 2004·Journal of Inherited Metabolic Disease·R J Desnick
Feb 5, 2005·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ed J WraithDoug A Brooks
Nov 3, 2005·Expert Opinion on Emerging Drugs·Gregory M Pastores, Natalie L Barnett
Mar 7, 2006·Molecular Genetics and Metabolism·Ernest Beutler
Apr 8, 2006·Molecular Genetics and Metabolism·Peter J MeikleJohn J Hopwood
Aug 17, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Joseph MuenzerAlan Kimura
Dec 23, 2006·Molecular Genetics and Metabolism·Joseph MuenzerAlan Kimura

❮ Previous
Next ❯

Citations

Nov 1, 2011·European Journal of Pediatrics·Joseph MuenzerPaul Harmatz
Aug 27, 2009·Biologics : Targets & Therapy·Jakub Tolar, Paul J Orchard
Aug 1, 2012·Drug Delivery and Translational Research·Jaspreet Singh KochharLifeng Kang
Nov 26, 2008·Best Practice & Research. Clinical Rheumatology·Gregory M Pastores
Jun 24, 2016·The Open Microbiology Journal·Edwin D Morales-ÁlvarezAura M Pedroza-Rodríguez
Nov 18, 2018·Italian Journal of Pediatrics·Daniela ConcolinoRossella Parini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Medical Genetics
Enrique Galán-GómezJuan J Cardesa-García
Pediatrics
Joseph MuenzerInternational Consensus Panel on Management and Treatment of Mucopolysaccharidosis I
Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
M Sheridan, I Johnston
© 2022 Meta ULC. All rights reserved